The Center for Orphan Drug Research at the University of Minnesota Invites applications for a one-year Translational Pharmacology Research Fellowship. The aim of the fellowship is to prepare translational scientists engaged in rare disease and orphan drug research in a collaborative, multidisciplinary environment, with a special focus on lysosomal diseases. This advanced training opportunity will serve as a foundation for the individual to subsequently develop a novel, independent translational research program that addresses therapeutic needs of patients with rare diseases.
The fellow will gain competency and achieve expertise in the research process for rare disease therapies through the conduct of laboratory and clinical studies along with advanced-level course work. Skills and knowledge that will be acquired include hypothesis generation; study design; protocol development; regulatory applications; grantsmanship; study coordination; laboratory training including analytical and molecular biology techniques; data collection, analysis and interpretation; presentation of results; and manuscript preparation. The fellow will also have the opportunity to take relevant advanced coursework e.g., clinical trial design, biostatistics, pharmacometrics, etc., participate in seminars, and gain clinical experience. He/she will have the opportunity to interact with internationally recognized scientists and clinicians working in the rare disease field. The fellow will be mentored by experienced faculty and staff at the Center for Orphan Drug Research. Toward the conclusion of the program, the fellow will have the opportunity to conduct independent research.
The opportunity to complete a second year of the fellowship will be contingent on the availability of funding.
The mission of the Center for Orphan Drug Research (CODR) is to improve the care of individuals with rare diseases through research, education, and involvement in shaping public policy applicable to rare diseases and orphan drugs. Members of the Center include clinicians, molecular and clinical pharmacologists, regulatory experts, laboratory staff, undergraduate and graduate students. The Center has focused on rare neurodegenerative diseases for the past decade and has secured funding from federal agencies, non-profit foundations and the pharmaceutical industry.
The successful candidate is expected to possess basic research expertise with an interest in clinical pharmacology. This program gives the opportunity for a fellow to build on his/her basic science skills and acquire new expertise to conduct translational/clinical research.
Required Qualifications: Earned Doctoral degree (PhD/PharmD/MD) from an accredited college/university Additional: Strong problem-solving skills Good written and oral communication skills Self-motivated learner
Preferred Qualifications: Degree or previous training in genetics and/or pharmacology Previous laboratory experience in molecular and cellular biology research or analytical chemistry Demonstrated interest and aptitude in combining basic concepts with clinical need that can impact the care of patients with rare diseases, specifically lysosomal diseases.
Internal Number: 335259
About University of Minnesota, Twin Cities
The University of Minnesota, founded in the belief that all people are enriched by understanding, is dedicated to the advancement of learning and the search for truth; to the sharing of this knowledge through education for a diverse community; and to the application of this knowledge to benefit the people of the state, the nation, and the world.